Chronic activation of the IL-6/JAK/STAT pathway in the tumor and its microenvironment produces a deregulated inflammatory cascade at cellular and systemic levels (increased C-reactive protein, neutrophil counts and decreased albumin) [20]. This evidence concerns the gene IL6 and neoplasm.